The landscape of biomedical research is undergoing a significant transformation. The National Institutes of Health (NIH) recently announced the launch of the Office of Research Innovation, Validation, and Application (ORIVA), a dedicated office focused on accelerating the development and adoption of human-based research technologies.
This initiative highlights a critical strategic shift within the NIH: prioritizing New Approach Methodologies (NAMs) such as 3D human tissue models and other animal-free methods to better reflect human biology and overcome the translational limitations often found in traditional animal models.
How PepGel Aligns with This New Era of Research
At PepGel, we recognize the urgency of this transition and understand that transitioning away from established animal models is a major undertaking. As researchers face increased pressure to adopt methods that are more replicable, translatable, and efficient, our PGmatrix™ product line provides the essential infrastructure needed for this next generation of bioscience. PepGel can help your team throughout this transition, including using parallel studies or completely animal-free models.
Our 3D cell culture solutions offer several advantages that align with the NIH’s new mission:
- True In Vivo-Like Biology: Our synthetic hydrogels provide a precisely controlled microenvironment that mimics the human extracellular matrix, allowing cells to behave more naturally than they would in traditional 2D culture, 3D suspension spheroids, or animal models.
- Scalability for Innovation: As the NIH works to validate and scale NAMs, PepGel’s platforms are designed for robust, reproducible experiments, supporting the infrastructure needs of modern laboratories.
- Animal-Free Consistency: By utilizing fully synthetic materials, researchers can eliminate the variability often associated with animal-derived hydrogels, ensuring that their findings are driven by human-relevant data.
We are committed to supporting the research community as you navigate these regulatory and methodological shifts. Whether you are developing complex organoids or high-throughput drug screening platforms, PepGel is here to help you bridge the gap toward more human-centric, animal-free research.
Are you ready to transition your lab to human-based 3D models? Contact our team today to learn how PepGel’s synthetic hydrogel can support your specific research goals and help you stay at the forefront of this innovative shift.
